A deadly disorder: During the pregnancy, doctors detected swelling, severe anemia, and a lack of oxygen in the fetus. The life-threatening symptoms were caused by alpha thalassemia major, a genetic blood disorder. Most babies with the condition are stillborn or die soon after birth.
The procedure: A team at the University of California, San Francisco extracted bone marrow from the mother-to-be between the 18th and 25th weeks of pregnancy and isolated stem cells from it. They then injected the cells into the fetus’s umbilical vein, allowing them to circulate through the bloodstream and develop into healthy blood cells.
Healthy baby: The infant was born in February, four months after undergoing the stem-cell transplant (that’s her, pictured above with her parents). It’s too early to know whether the treatment is a cure, but doctors hope to use the approach to eliminate beta thalassemia, the more common form of the disease, as well as sickle-cell anemia and other serious genetic disorders.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
How do strong muscles keep your brain healthy?
There’s a robust molecular language being spoken between your muscles and your brain.
The quest to show that biological sex matters in the immune system
A handful of immunologists are pushing the field to take attributes such as sex chromosomes, sex hormones, and reproductive tissues into account.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.